Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| C4 Therapeutics, Inc. | 107,939 | reported | 14 Feb 2025 | tx 38+938,000−252,211 |
| Neon Therapeutics, Inc. | 0 | reported | 06 May 2020 | tx 9+230,000−330,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 Feb 2025 | GRANT_AWARD | C4 Therapeutics, Inc. | 56,500 | 0.00 USD | |
| 13 Feb 2025 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 2,135 | 3.20 USD | |
| 14 Feb 2025 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 2,914 | 3.18 USD | |
| 14 Feb 2025 | GRANT_AWARD | C4 Therapeutics, Inc. | 84,700 | 0.00 USD | deriv |
| 07 Nov 2024 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 1,102 | 6.04 USD | |
| 07 Nov 2024 | EXERCISE | C4 Therapeutics, Inc. | 3,750 | — | |
| 07 Nov 2024 | EXERCISE | C4 Therapeutics, Inc. | 3,750 | 0.00 USD | deriv |
| 16 Sept 2024 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 661 | 6.36 USD | |
| 16 Sept 2024 | EXERCISE | C4 Therapeutics, Inc. | 2,250 | — | |
| 16 Sept 2024 | EXERCISE | C4 Therapeutics, Inc. | 2,250 | 0.00 USD | deriv |
| 07 Mar 2024 | GRANT_AWARD | C4 Therapeutics, Inc. | 90,000 | 0.00 USD | deriv |
| 07 Mar 2024 | OTHER | C4 Therapeutics, Inc. | 90,000 | 0.00 USD | deriv |
| 07 Mar 2024 | GRANT_AWARD | C4 Therapeutics, Inc. | 84,850 | 0.00 USD | deriv |
| 07 Mar 2024 | OTHER | C4 Therapeutics, Inc. | 84,850 | 0.00 USD | deriv |
| 14 Feb 2024 | GRANT_AWARD | C4 Therapeutics, Inc. | 27,300 | 0.00 USD | |
| 13 Feb 2024 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 1,735 | 6.53 USD | |
| 14 Feb 2024 | GRANT_AWARD | C4 Therapeutics, Inc. | 122,800 | 0.00 USD | deriv |
| 18 Sept 2023 | GRANT_AWARD | C4 Therapeutics, Inc. | 120,000 | 0.00 USD | deriv |
| 30 Aug 2023 | EXERCISE | C4 Therapeutics, Inc. | 2,250 | — | |
| 30 Aug 2023 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 661 | 2.93 USD | |
| 30 Aug 2023 | EXERCISE | C4 Therapeutics, Inc. | 2,250 | 0.00 USD | deriv |
| 13 Feb 2023 | GRANT_AWARD | C4 Therapeutics, Inc. | 20,000 | 0.00 USD | |
| 13 Feb 2023 | GRANT_AWARD | C4 Therapeutics, Inc. | 90,000 | 0.00 USD | deriv |
| 30 Jan 2023 | TAX_WITHHOLDING | C4 Therapeutics, Inc. | 1,301 | 7.78 USD | |
| 30 Jan 2023 | EXERCISE | C4 Therapeutics, Inc. | 3,750 | — |